Written question asked by Johanna Baxter (Labour) on Tuesday, 18 November 2025, in the House of Commons. It was due for an answer on Thursday, 20 November 2025. It was answered by Ashley Dalton (Labour) on Wednesday, 26 November 2025 on behalf of the Department of Health and Social Care.
Disease Control: Immunosuppression
- Question
-
To ask the Secretary of State for Health and Social Care, what engagement did Exercise Pegasus have with pharmaceutical providers on the procurement of pre-prophylactic drugs for immunocompromised patients.
- Answer
-
Exercise PEGASUS, the largest simulation of a pandemic in United Kingdom history, involved thousands of participants across different parts of the exercise. Multiple other non-Governmental organisations representing the breadth of society were engaged and will continue to be in advance of phase four of the exercise in 2026. This includes engagement with partners from across the pharmaceutical industry, a focus group with those who are clinically vulnerable, and engagement with our key personal protective equipment (PPE) delivery partner SCCL on the PPE requirements across health and social care on the core anchor days of the exercise.
Secondary information
- Type
- Written question
- Reference
- 92251
- Session
- 2024-26
- Registered interest declared
- Yes
- Grouped for answer
- Yes
- Transferred
- Yes
- Subjects
- Disease control Immunosuppression Preventive medicine
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-01-05 14:44:03 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/92251
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/92251
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-26/92251